<!DOCTYPE html>
<html lang="en">

<head>

  <meta charset="UTF-8">

  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <meta http-equiv="Content-Security-Policy" content="default-src 'self'; img-src 'self' data:; style-src 'self' 'unsafe-inline' https://fonts.googleapis.com https://fonts.gstatic.com; font-src https://fonts.googleapis.com https://fonts.gstatic.com;">

  <meta name="description" content="pub.healthcare — Free healthcare for all citizens of USA and Norway: Revolutionary platform combining automated pharmaceutical manufacturing, parametric hospitals, and AI diagnostics to serve 345 million people.">

  <meta name="keywords" content="pub.healthcare, free healthcare, autonomous hospital, parametric architecture, AI, robotics, automated pharmacy, Norway, USA, universal healthcare, hAPI, pharmaceutical manufacturing">

  <meta name="author" content="PubHealthcare AS">

  <link rel="preconnect" href="https://fonts.googleapis.com">

  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>

  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600&family=Montserrat+Alternates:wght@700&display=swap" rel="stylesheet" font-display="swap">

  <title>pub.healthcare — Free Healthcare for USA + Norway</title>

  <style>

    :root {

      --primary-color: #d3d3d3;

      --background-color: #ffffff;

      --text-color: #000000;

      --accent-color: #d32f2f;

      --neutral-light: #e0e0e0;

      --neutral-dark: #757575;

      --font-family: 'Inter', system-ui, -apple-system, Segoe UI, Roboto, sans-serif;

      --heading-font-family: 'Montserrat Alternates', sans-serif;

      --base-font-size: 15px;

      --line-height: 1.6;

    }

    * { box-sizing: border-box; margin: 0; padding: 0; }

    body { font-family: var(--font-family); font-size: var(--base-font-size); line-height: var(--line-height); color: var(--text-color); background: var(--background-color); padding: 1rem; }

    main { max-width: 74ch; margin: 0 auto; }

    h1, h2 { font-family: var(--heading-font-family); font-weight: 700; color: var(--primary-color); letter-spacing: 0.04em; }

    h1 { font-size: 2.4rem; margin-bottom: 1rem; }

    h2 { font-size: 1.8rem; margin-top: 1.6rem; margin-bottom: 0.6rem; color: #111; }

    h3 { font-size: 1.2rem; margin-top: 1rem; margin-bottom: 0.4rem; }

    p { margin: 0.5rem 0 0.8rem; }

    ul { margin: 0.4rem 0 0.8rem 1.1rem; }

    li { margin: 0.35rem 0; }

    a { color: var(--accent-color); text-decoration: none; font-weight: 500; }

    a:hover, a:focus { color: #b71c1c; text-decoration: underline; outline: none; }

    address { font-style: normal; color: var(--neutral-dark); margin-bottom: 1rem; }

    time { color: var(--neutral-dark); }

    .warning_box { padding: 0.8rem; margin: 1.1rem 0; border-left: 3px solid var(--accent-color); background: #fff; border-radius: 2px; }

    .warning_title { font-weight: 600; color: var(--accent-color); text-transform: uppercase; margin-bottom: 0.25rem; }

    table { width: 100%; border-collapse: collapse; margin: 1rem 0; background: #fff; }

    th, td { padding: 0.6rem 0.7rem; border-bottom: 1px solid var(--neutral-light); text-align: left; }

    th { background: #f3f3f3; position: sticky; top: 0; z-index: 1; }

    tr:nth-child(even) td { background: #fafafa; }

    caption { caption-side: top; text-align: left; font-weight: 600; margin-bottom: 0.4rem; }

    footer { font-size: 0.9rem; color: var(--neutral-dark); text-align: center; padding: 1rem 0; margin-top: 1.5rem; border-top: 1px solid var(--neutral-light); }

    .footer-links { margin-top: 0.4rem; display: flex; justify-content: center; gap: 0.8rem; }

    .badge { display: inline-block; padding: 0.15rem 0.45rem; font-size: 0.85rem; border: 1px solid var(--neutral-light); border-radius: 999px; color: #333; background: #f9f9f9; }

    @media (min-width: 768px) { body { padding: 1.6rem 1rem; } h1 { font-size: 2.8rem; } h2 { font-size: 2rem; } }

    @media print {

      body { padding: 12mm; }

      a[href^="http"]::after { content: " (" attr(href) ")"; font-weight: 400; }

      footer { position: fixed; bottom: 0; left: 0; right: 0; background: none; border: 0; }

    }

  </style>

</head>

<body>

  <main>

    <header>

      <h1>pub.healthcare — Free Healthcare for USA + Norway</h1>

      <address>

        <p>PubHealthcare AS, Kanalveien 10, 5068 Bergen • <b><a href="mailto:info@pub.healthcare" aria-label="Email PubHealthcare AS">info@pub.healthcare</a></b></p>

        <p><span class="badge">Framework: master.json v502.0.0</span> <span class="badge">Flagship Company</span> <span class="badge">Innovasjon Norge NOK 25M</span></p>

        <p><time datetime="2025-10-17">17 October 2025</time></p>

      </address>

    </header>

    <section aria-labelledby="exec">
      <h2 id="exec">Executive summary</h2>

      <p><strong>pub.healthcare is the flagship company</strong> with the bold mission: <strong>"Free healthcare for all citizens of USA and Norway"</strong> — making healthcare universally accessible at zero cost to patients for <strong>345 million people</strong>.</p>

      <p>This is not just automated pharmaceutical manufacturing or parametric hospitals — this is a <strong>revolutionary healthcare delivery platform</strong> that combines three core innovations:</p>

      <ol>
        <li><strong>Automated Pharmaceutical Manufacturing</strong>: On-demand medication production eliminates 40% of healthcare costs through zero markup and local production</li>
        <li><strong>Parametric Hospital Architecture</strong>: AI-designed modular hospitals built in 90 days with 60% construction cost reduction using SYRE™ 3D printing</li>
        <li><strong>AI Diagnostic System (hAPI)</strong>: Free telemedicine with AI-driven diagnosis reducing specialist costs by 70%</li>
      </ol>

      <p><strong>Market Impact:</strong> Norway (5.5M people, NOK 400B healthcare spend) serves as proof of concept, demonstrating 30% cost savings. USA expansion (340M people, $4.5T spend) achieves $1.5 trillion annual savings, funding universal coverage through automation efficiency.</p>

      <p><strong>Funding Request:</strong> NOK 25M from Innovasjon Norge for Norwegian pilot with UNN (University Hospital of North Norway), targeting 50K patients in Year 1 with validated 30% cost reduction and >90% patient satisfaction.</p>

    </section>

    <section aria-labelledby="mission">
      <h2 id="mission">Core Mission</h2>

      <p style="font-size: 1.2em; font-weight: 600; color: var(--accent-color); margin: 1.5rem 0;">"Making healthcare free, accessible, and excellent for 340 million Americans and 5.5 million Norwegians"</p>

      <h3>The Healthcare Crisis</h3>

      <ul>
        <li><strong>Unaffordable Care:</strong> Americans spend $5,000–15,000/year on health insurance while 8% remain uninsured</li>
        <li><strong>Pharmaceutical Costs:</strong> 40% of healthcare spending goes to medications with artificial markups</li>
        <li><strong>Access Gaps:</strong> Rural hospital closures, urban ER overcrowding, 2–6 month specialist wait times in Norway</li>
        <li><strong>Infrastructure Burden:</strong> Conventional hospitals cost $150M and take 3+ years to build</li>
        <li><strong>System Inefficiency:</strong> Administrative overhead, fragmented care, workforce burnout</li>
      </ul>

      <h3>Why Free Healthcare Is Possible Now</h3>

      <p>Healthcare costs are inflated by middlemen, legacy infrastructure, and manual processes. <strong>Automation technology has reached the point where we can eliminate these costs:</strong></p>

      <ul>
        <li>Automated medication production removes pharmaceutical distributor markups (40% cost reduction)</li>
        <li>Parametric hospital design with 3D printing cuts construction costs by 60% (90 days vs 3 years)</li>
        <li>AI diagnostics reduce specialist consultation needs by 70% while improving accuracy</li>
        <li>Distributed local production eliminates transportation and storage costs</li>
      </ul>

      <p><strong>Key Insight:</strong> The cost savings from automation are sufficient to provide free healthcare to all citizens. This is economically sustainable, not charity.</p>

    </section>

    <section aria-labelledby="solution">
      <h2 id="solution">How We Achieve Free Healthcare: The Three Pillars</h2>

      <h3>1. Automated Pharmaceutical Manufacturing (Foundation)</h3>

      <p><strong>The Problem:</strong> Pharmaceutical costs account for 40% of total healthcare spending, primarily due to middleman markups, patents, and centralized production requiring expensive distribution networks.</p>

      <p><strong>Our Solution:</strong></p>
      <ul>
        <li><strong>On-demand production:</strong> Every hospital and community location has automated medication synthesis capabilities</li>
        <li><strong>Zero markup:</strong> Direct production eliminates pharmaceutical distributor profits</li>
        <li><strong>Local production:</strong> No transportation costs, cold chain requirements, or inventory waste</li>
        <li><strong>Generic formulations:</strong> Focus on essential medications (WHO Essential Medicines List)</li>
        <li><strong>Quality control:</strong> Automated testing and certification at point of production</li>
      </ul>

      <p><strong>Impact:</strong> 40% reduction in healthcare costs funds free medication for all patients. Norwegian pilot: 47 municipalities without pharmacies gain access.</p>

      <h3>2. Parametric Hospital Architecture (Integration with SPEIS + SYRE™)</h3>

      <p><strong>The Problem:</strong> Traditional hospitals cost $150M and take 3+ years to build. Fixed layouts can't adapt to changing needs (pandemics, demographic shifts).</p>

      <p><strong>Our Solution:</strong></p>
      <ul>
        <li><strong>AI-designed modular hospitals:</strong> Grasshopper/Rhino parametric algorithms optimize layouts for patient flow, infection control, and energy efficiency</li>
        <li><strong>90-day construction:</strong> Pre-fabricated modules manufactured using SYRE™ 3D printing technology (carbon fiber + advanced composites)</li>
        <li><strong>60% cost reduction:</strong> 100-bed hospital for $15M instead of $150M</li>
        <li><strong>Shared engineering:</strong> SPEIS aerospace structural engineers provide materials science and parametric optimization expertise</li>
        <li><strong>Adaptive infrastructure:</strong> Modules reconfigure in minutes (med-surg → ICU → step-down)</li>
        <li><strong>Energy self-sufficiency:</strong> On-site renewables and waste-heat recovery</li>
      </ul>

      <p><strong>Example:</strong> UNN (University Hospital of North Norway) pilot wing: 50-bed parametric module with integrated automated pharmacy, built in 90 days for $7.5M.</p>

      <h3>3. AI Diagnostic System (hAPI Platform)</h3>

      <p><strong>The Problem:</strong> Specialist consultations cost $200–500 per visit with 2–6 month wait times. Primary care bottlenecks delay diagnosis and treatment.</p>

      <p><strong>Our Solution:</strong></p>
      <ul>
        <li><strong>Free telemedicine for all citizens:</strong> No consultation fees, available 24/7 via web/mobile</li>
        <li><strong>AI-driven diagnosis:</strong> DeepSeek medical models analyze symptoms, medical history, and real-time data</li>
        <li><strong>70% cost reduction:</strong> AI handles routine cases, specialists focus on complex conditions</li>
        <li><strong>Ruby/LangChain.rb powered:</strong> Native integration with Norwegian "Helsenorge.no" and US "healthcare.gov"</li>
        <li><strong>Privacy-preserving:</strong> On-premise inference, GDPR/HIPAA compliant, patient data sovereignty</li>
        <li><strong>Human oversight:</strong> All AI recommendations reviewed by licensed clinicians before prescription</li>
      </ul>

      <p><strong>Integration Flow:</strong> Patient describes symptoms → AI diagnosis → Automated pharmacy produces medication (if needed) → Parametric hospital appointment (if needed) → Patient pays $0/0 NOK</p>

    </section>

    <section aria-labelledby="revenue">
      <h2 id="revenue">Revenue Model: How "Free" Actually Works</h2>

      <h3>Norway Model (Easier Path — Proof of Concept)</h3>

      <p><strong>Current State:</strong></p>
      <ul>
        <li>Population: 5.5 million</li>
        <li>Annual healthcare spend: NOK 400B (~$37B USD)</li>
        <li>System: Tax-funded universal coverage with long wait times</li>
      </ul>

      <p><strong>pub.healthcare Approach:</strong></p>
      <ul>
        <li><strong>Government contracts with Helsedirektoratet:</strong> Replace existing healthcare budget allocation</li>
        <li><strong>30% cost savings:</strong> Deliver same care for NOK 280B through automation (NOK 120B annual savings)</li>
        <li><strong>Savings reinvestment:</strong> Expanded coverage, preventative care, reduced wait times</li>
        <li><strong>Patient experience:</strong> Zero cost at point of care (Norwegian tradition maintained)</li>
        <li><strong>Revenue source:</strong> Government funding covers operations via demonstrated efficiency gains</li>
      </ul>

      <p><strong>Why Norway First:</strong> Established universal healthcare culture, government willingness to fund innovation (Innovasjon Norge), smaller scale for validation, strong digital infrastructure (Helsenorge.no), cultural emphasis on "likemannsbehandling" (equal treatment).</p>

      <h3>USA Model (Scalable — Global Expansion)</h3>

      <p><strong>Current State:</strong></p>
      <ul>
        <li>Population: 340 million</li>
        <li>Annual healthcare spend: $4.5 trillion</li>
        <li>System: Private insurance + Medicare/Medicaid, 8% uninsured, bankruptcies common</li>
      </ul>

      <p><strong>pub.healthcare Approach (Multi-Channel):</strong></p>

      <ol>
        <li><strong>Direct-to-Consumer Subscription:</strong>
          <ul>
            <li>$0/month for basic care (telemedicine + essential medications)</li>
            <li>Optional premium tiers: $50–100/month for priority access, elective procedures</li>
            <li>No deductibles, no copays, no claim denials</li>
          </ul>
        </li>
        <li><strong>Employer Partnerships:</strong>
          <ul>
            <li>Replace company health insurance with pub.healthcare subscriptions</li>
            <li>50% cost savings for employers (vs $15K/employee current average)</li>
            <li>B2B contracts with Fortune 500 companies for employee coverage</li>
          </ul>
        </li>
        <li><strong>Medicare/Medicaid Contracts:</strong>
          <ul>
            <li>Automated billing integration with CMS (Centers for Medicare & Medicaid Services)</li>
            <li>Cost-plus model: government pays actual costs + 10% margin</li>
            <li>Demonstrate savings vs traditional Medicare Advantage plans</li>
          </ul>
        </li>
        <li><strong>Philanthropic Funding:</strong>
          <ul>
            <li>Partner with Gates Foundation, Chan Zuckerberg Initiative, Bloomberg Philanthropies</li>
            <li>Grants cover operations in underserved communities (rural healthcare deserts)</li>
          </ul>
        </li>
        <li><strong>Cross-Subsidization:</strong>
          <ul>
            <li>Premium services for wealthy patients (concierge medicine, elective cosmetic procedures)</li>
            <li>Revenue from profitable services subsidizes free care for low-income patients</li>
            <li>"1:1 model" (like SYRE™ footwear): Every 1 paying patient funds 1 free patient</li>
          </ul>
        </li>
      </ol>

      <p><strong>Key Differentiator:</strong> Unlike traditional insurance (profit from denying care), pub.healthcare profits from delivering care efficiently through automation. Aligned incentives create sustainable economics.</p>

    </section>

    <section aria-labelledby="market">
      <h2 id="market">Market Size &amp; Impact</h2>

      <table role="grid" aria-label="Market size and impact comparison">
        <caption>Global Healthcare Market Opportunity</caption>
        <thead>
          <tr>
            <th scope="col">Region</th>
            <th scope="col">Population</th>
            <th scope="col">Current Spend</th>
            <th scope="col">pub.healthcare Target</th>
            <th scope="col">Annual Savings</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td scope="row"><strong>Norway</strong></td>
            <td>5.5M</td>
            <td>NOK 400B ($37B)</td>
            <td>NOK 280B ($26B)</td>
            <td>NOK 120B ($11B)</td>
          </tr>
          <tr>
            <td scope="row"><strong>USA</strong></td>
            <td>340M</td>
            <td>$4.5 trillion</td>
            <td>$3.0 trillion</td>
            <td>$1.5 trillion</td>
          </tr>
          <tr class="total-row">
            <td scope="row"><strong>Combined</strong></td>
            <td><strong>345M</strong></td>
            <td><strong>$4.54T</strong></td>
            <td><strong>$3.03T</strong></td>
            <td><strong>$1.51T</strong></td>
          </tr>
        </tbody>
      </table>

      <h3>Impact Beyond Cost Savings</h3>

      <ul>
        <li><strong>345 million people</strong> with free, high-quality healthcare (equal treatment regardless of income)</li>
        <li><strong>$1.5 trillion annual savings</strong> redirected to universal coverage, preventative care, medical research</li>
        <li><strong>500,000 jobs created</strong> (software engineers, AI specialists, pharmacists, doctors, construction workers)</li>
        <li><strong>Healthcare bankruptcy elimination</strong> (USA: 530,000 families/year currently)</li>
        <li><strong>Preventative care focus</strong> reduces long-term costs and improves population health</li>
        <li><strong>Global healthcare system disruption</strong> forces competitors to adopt automation or become obsolete</li>
      </ul>

      <h3>Target Customers</h3>

      <p><strong>Norway (Phase 1-2):</strong></p>
      <ul>
        <li>Helsedirektoratet (national health directorate) for government contracts</li>
        <li>Regional health authorities (Helse Nord, Helse Midt, Helse Vest, Helse Sør-Øst)</li>
        <li>UNN (University Hospital of North Norway) as pilot partner</li>
        <li>Norwegian municipalities without pharmacy access (47 currently)</li>
      </ul>

      <p><strong>USA (Phase 3-5):</strong></p>
      <ul>
        <li>Medicare/Medicaid beneficiaries (130M people, $1.4T annual spend)</li>
        <li>Uninsured/underinsured individuals (30M people seeking affordable care)</li>
        <li>Employers seeking health benefit cost reduction (Fortune 500 → SMBs)</li>
        <li>Rural healthcare deserts (63M Americans in counties with limited access)</li>
        <li>State Medicaid programs (particularly expansion states like California, New York)</li>
      </ul>

    </section>

    <section aria-labelledby="tech">
      <h2 id="tech">Technology Stack: Unified Platform</h2>

      <h3>1. hAPI (Healthcare API) — Ruby/LangChain.rb Platform</h3>

      <p>Unified healthcare platform connecting patients, AI diagnostics, automated pharmacies, and parametric hospitals:</p>

      <div class="warning_box" role="note">
        <pre style="background: #f5f5f5; padding: 1rem; overflow-x: auto; border-radius: 3px; font-family: 'Courier New', monospace; font-size: 0.85rem; line-height: 1.4;">
<code># Unified healthcare platform: Patients → AI → Pharmacy → Hospitals
# Integration: Helsenorge (Norway) + healthcare.gov (USA)

class hAPI
  def initialize(patient_id, country: :norway)
    @patient = Patient.find(patient_id)
    @country = country
    @ai_diagnostician = DeepSeekMedical.new
    @pharmacy = AutomatedPharmacy.nearest(@patient.location)
    @hospital_network = ParametricHospital.network(@country)
  end
  
  def free_consultation
    # Step 1: Patient describes symptoms via web/mobile
    symptoms = @patient.describe_symptoms
    
    # Step 2: AI analyzes with medical history
    diagnosis = @ai_diagnostician.analyze(
      symptoms, 
      @patient.history,
      privacy: :on_premise  # GDPR/HIPAA compliant
    )
    
    # Step 3: Automated medication production (if needed)
    if diagnosis.requires_medication?
      prescription = generate_prescription(diagnosis)
      @pharmacy.produce_medication(
        prescription, 
        cost: 0  # Zero cost to patient
      )
      deliver_or_pickup(prescription)
    end
    
    # Step 4: Hospital appointment booking (if needed)
    if diagnosis.requires_hospitalization?
      @hospital_network.book_appointment(
        @patient, 
        urgency: diagnosis.severity,
        module: select_optimal_module(diagnosis)
      )
    end
    
    # Step 5: Billing (patient pays nothing)
    bill_to_government_or_insurance(diagnosis, @country)
    
    # Patient total cost: $0 / 0 NOK
  end
  
  private
  
  def bill_to_government_or_insurance(diagnosis, country)
    case country
    when :norway
      # Bill to Helsedirektoratet via existing budget
      NorwegianHealth.submit_claim(diagnosis, cost_savings: 0.30)
    when :usa
      # Multi-channel: Medicare/Medicaid/Employer/Subscription
      USHealthcare.route_billing(diagnosis, @patient.insurance_type)
    end
  end
end</code></pre>
      </div>

      <h3>2. Parametric Hospital Design (SPEIS + SYRE™ Integration)</h3>

      <ul>
        <li><strong>Design Tools:</strong> Grasshopper/Rhino algorithms for optimal hospital layouts (patient flow, infection control, structural integrity)</li>
        <li><strong>SPEIS Collaboration:</strong> Aerospace structural engineers provide carbon fiber materials, FEA (Finite Element Analysis), and AI³ building automation</li>
        <li><strong>SYRE™ 3D Printing:</strong> Modular construction components manufactured with same technology as SYRE footwear (advanced composites, rapid prototyping)</li>
        <li><strong>Example Specs:</strong>
          <ul>
            <li>100-bed hospital: $15M cost, 90-day build (vs $150M, 3 years traditional)</li>
            <li>Modular units: 5m × 5m × 3m pre-fabricated pods (patient rooms, ORs, diagnostic labs)</li>
            <li>Reconfiguration: 2 hours to convert med-surg → ICU → step-down</li>
          </ul>
        </li>
        <li><strong>Smart Building:</strong> AI³ integration for HVAC optimization, biosafety monitoring, energy management</li>
      </ul>

      <h3>3. Distributed Pharmacy Network</h3>

      <p><strong>Deployment Strategy:</strong></p>
      <ul>
        <li><strong>Hospital Integration:</strong> Every parametric hospital has automated medication production lab</li>
        <li><strong>Community "Medication ATMs":</strong> Standalone units in rural areas (Norway: 47 municipalities without pharmacies)</li>
        <li><strong>USA Rollout:</strong> 5,000 locations by Year 5 (partnership with CVS/Walgreens for real estate, replace traditional pharmacies)</li>
        <li><strong>Production Capacity:</strong> Each unit produces 500 prescriptions/day (WHO Essential Medicines List: 500+ formulations)</li>
      </ul>

      <p><strong>Quality &amp; Safety:</strong></p>
      <ul>
        <li>Automated synthesis with real-time quality control (GC-MS verification)</li>
        <li>Regulatory compliance: Norwegian Medicines Agency + FDA approval for each formulation</li>
        <li>Blockchain tracking: Full traceability from raw materials to patient delivery</li>
        <li>Cold chain elimination: On-demand production removes storage/transport requirements</li>
      </ul>

      <h3>4. Platform Integration</h3>

      <ul>
        <li><strong>Norway:</strong> Helsenorge.no national patient portal (OAuth integration, patient data sync)</li>
        <li><strong>USA:</strong> healthcare.gov marketplace (API access for eligibility verification)</li>
        <li><strong>Security:</strong> OpenBSD-hardened control plane, zero-trust network, on-premise AI inference</li>
        <li><strong>Interoperability:</strong> HL7 FHIR compatibility today; hAPI standard for future expansion</li>
        <li><strong>Privacy:</strong> GDPR (Norway/EU) and HIPAA (USA) compliant, patient data sovereignty</li>
      </ul>

      <div class="warning_box" role="note" aria-labelledby="note-standards">
        <div class="warning_title" id="note-standards">Standards &amp; Compliance</div>
        <p>All PHI (Protected Health Information) processing complies with GDPR (Norway) and HIPAA (USA) under least-privilege access. Interoperability aligns with HL7 FHIR; future upgrades to hAPI drafts preserve backward compatibility. Pharmaceutical production follows Norwegian Medicines Agency and FDA Good Manufacturing Practice (GMP) guidelines.</p>
      </div>

    </section>

    <section aria-labelledby="innovasjon">
      <h2 id="innovasjon">Innovasjon Norge Pitch: Norwegian Pilot</h2>

      <h3>Phase 1: Norwegian Proof of Concept (Years 1-2)</h3>

      <p><strong>Funding Request: NOK 25 million</strong> (increased from NOK 7.5M — this is flagship-scale innovation)</p>

      <table role="grid" aria-label="Norwegian pilot funding breakdown">
        <caption>Phase 1 Budget Allocation (NOK 25M)</caption>
        <thead>
          <tr>
            <th scope="col">Category</th>
            <th scope="col">Amount (NOK)</th>
            <th scope="col">Purpose</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Parametric Hospital Wing</td>
            <td>12M</td>
            <td>50-bed UNN pilot module with SYRE™ 3D printing</td>
          </tr>
          <tr>
            <td>Automated Pharmacy System</td>
            <td>6M</td>
            <td>Medication production lab + 5 community ATM units</td>
          </tr>
          <tr>
            <td>hAPI Platform Development</td>
            <td>4M</td>
            <td>Ruby/LangChain.rb + Helsenorge.no integration</td>
          </tr>
          <tr>
            <td>Clinical Validation &amp; Regulatory</td>
            <td>2M</td>
            <td>Norwegian Medicines Agency approval + clinical trials</td>
          </tr>
          <tr>
            <td>Staff Training &amp; Operations</td>
            <td>1M</td>
            <td>UNN medical staff training on new systems</td>
          </tr>
        </tbody>
      </table>

      <p><strong>Partner: UNN (University Hospital of North Norway)</strong></p>
      <ul>
        <li>Deploy: Automated pharmacy + hAPI telemedicine platform + 50-bed parametric hospital wing</li>
        <li>Target: Serve 50,000 patients in Northern Norway (Tromsø, Bodø, Narvik regions)</li>
        <li>Timeline: 18 months from funding to full operation</li>
      </ul>

      <p><strong>Success Metrics (Validated by Helsedirektoratet):</strong></p>
      <ul>
        <li><strong>Cost Reduction:</strong> 30% savings vs traditional care delivery (documented via government audit)</li>
        <li><strong>Patient Satisfaction:</strong> >90% satisfaction score (survey of 10K+ patients)</li>
        <li><strong>Wait Time Reduction:</strong> Specialist consultations from 6 months → 1 week average</li>
        <li><strong>Medication Access:</strong> 100% of prescriptions available within 24 hours (vs 2-5 days traditional pharmacy)</li>
        <li><strong>Health Outcomes:</strong> Improved chronic disease management (diabetes, hypertension monitoring)</li>
      </ul>

      <h3>Phase 2: Norwegian National Rollout (Years 3-5)</h3>

      <ul>
        <li><strong>Scale to all 4 health regions:</strong> Helse Nord, Helse Midt-Norge, Helse Vest, Helse Sør-Øst</li>
        <li><strong>Full Helsenorge.no integration:</strong> National patient portal with hAPI backend</li>
        <li><strong>Coverage:</strong> 5.5M Norwegians with free healthcare (government-funded through demonstrated savings)</li>
        <li><strong>Investment:</strong> NOK 150M (combination of government budget replacement + private investment)</li>
      </ul>

      <h3>Phase 3: USA Expansion (Years 5-10)</h3>

      <ul>
        <li><strong>Replicate Norwegian model:</strong> Start in rural US healthcare deserts (Montana, Wyoming, Alaska)</li>
        <li><strong>Medicare/Medicaid pilots:</strong> Partner with CMS for demonstration projects</li>
        <li><strong>Scale to 340M Americans:</strong> Replace private insurance with cost-effective automation model</li>
        <li><strong>Investment:</strong> $5B Series A-C funding (venture capital + philanthropic partnerships)</li>
      </ul>

    </section>

    <section aria-labelledby="norwegian-culture">
      <h2 id="norwegian-culture">Norwegian Cultural Framing</h2>

      <h3>"Dugnad for Global Helse" — Norway Leads, The World Follows</h3>

      <p style="font-style: italic; color: var(--neutral-dark); margin: 1rem 0;">Dugnad: Norwegian tradition of communal work for the common good. pub.healthcare embodies this spirit on a global scale.</p>

      <p><strong>Why This Matters to Norway:</strong></p>
      <ul>
        <li><strong>Pioneer Role:</strong> Norway leads global free healthcare model (like pension system innovation, sovereign wealth fund management)</li>
        <li><strong>"Likemannsbehandling" Exported:</strong> Norwegian principle of equal treatment for all, regardless of income, becomes global standard</li>
        <li><strong>Solving American Crisis:</strong> Norwegian innovation addresses US healthcare bankruptcy epidemic (530K families/year)</li>
        <li><strong>Moral Leadership:</strong> Positions Norway as both technological and ethical leader in universal healthcare</li>
        <li><strong>Economic Opportunity:</strong> Norwegian technology (SYRE™, SPEIS, hAPI) exported globally, creates high-value jobs</li>
      </ul>

      <p><strong>Historical Parallels:</strong></p>
      <ul>
        <li><strong>Oil Fund (1990):</strong> Norway managed resource wealth sustainably → global model for sovereign funds</li>
        <li><strong>Electric Vehicles (2010s):</strong> Norway's EV adoption leadership → EU/US policy changes</li>
        <li><strong>Universal Healthcare (2025+):</strong> Norway's automation model → global healthcare transformation</li>
      </ul>

      <p style="font-weight: 600; color: var(--accent-color); margin-top: 1.5rem;">Norway's population (5.5M) becomes proof of concept for USA (340M) and eventually global rollout (8 billion). Small country, massive impact.</p>

    </section>

    <section aria-labelledby="competitive">
      <h2 id="competitive">Competitive Advantage</h2>

      <table role="grid" aria-label="Competitive analysis comparison">
        <caption>pub.healthcare vs Traditional Healthcare Models</caption>
        <thead>
          <tr>
            <th scope="col">Feature</th>
            <th scope="col">pub.healthcare</th>
            <th scope="col">US Insurance Model</th>
            <th scope="col">Norwegian Public Model</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td scope="row"><strong>Cost to Patient</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">$0 / 0 NOK</td>
            <td>$5,000-15,000/year</td>
            <td>0 NOK (tax-funded)</td>
          </tr>
          <tr>
            <td scope="row"><strong>Wait Times</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">24h medication, 1 week specialist</td>
            <td>Varies (insurance dependent)</td>
            <td>2-6 months specialist</td>
          </tr>
          <tr>
            <td scope="row"><strong>Coverage</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">Universal (100%)</td>
            <td>92% of US population</td>
            <td>100% of Norway</td>
          </tr>
          <tr>
            <td scope="row"><strong>Technology</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">AI + Automation</td>
            <td>Manual + Legacy systems</td>
            <td>Digital, but not automated</td>
          </tr>
          <tr>
            <td scope="row"><strong>Scalability</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">Global</td>
            <td>USA only</td>
            <td>Norway only</td>
          </tr>
          <tr>
            <td scope="row"><strong>Hospital Construction</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">90 days, $15M</td>
            <td>3+ years, $150M</td>
            <td>2-4 years, $100M+</td>
          </tr>
          <tr>
            <td scope="row"><strong>Medication Access</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">On-demand, local production</td>
            <td>Pharmacy dependent</td>
            <td>Pharmacy dependent</td>
          </tr>
          <tr>
            <td scope="row"><strong>Aligned Incentives</strong></td>
            <td style="background: #e8f5e9; font-weight: 600;">Profit from efficiency</td>
            <td>Profit from denying care</td>
            <td>Budget constrained</td>
          </tr>
        </tbody>
      </table>

      <p><strong>Key Differentiator:</strong> pub.healthcare is the only model that makes free healthcare economically sustainable through automation. Traditional models rely on rationing (wait times) or exclusion (insurance denials). We eliminate the need for rationing by reducing costs 30-40%.</p>

    </section>

    <section aria-labelledby="financials">
      <h2 id="financials">Financial Model: 10-Year Projections</h2>

      <p><strong>Funding Request: NOK 25M from Innovasjon Norge</strong> (Phase 1 Norwegian pilot)</p>

      <table role="grid" aria-label="10-year financial projections">
        <caption>Revenue, Costs, and Patient Reach (USD)</caption>
        <thead>
          <tr>
            <th scope="col">Year</th>
            <th scope="col">Countries</th>
            <th scope="col">Patients Served</th>
            <th scope="col">Revenue</th>
            <th scope="col">Costs</th>
            <th scope="col">Net Profit</th>
            <th scope="col">Funding Source</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td scope="row">1</td>
            <td>Norway (pilot)</td>
            <td>50K</td>
            <td>$14M (NOK 150M)</td>
            <td>$17M (NOK 180M)</td>
            <td style="color: #d32f2f;">-$3M</td>
            <td>Innovasjon Norge + Helsedirektoratet</td>
          </tr>
          <tr>
            <td scope="row">2</td>
            <td>Norway (expansion)</td>
            <td>500K</td>
            <td>$140M (NOK 1.5B)</td>
            <td>$112M (NOK 1.2B)</td>
            <td style="color: #4caf50; font-weight: 600;">+$28M</td>
            <td>Government contracts</td>
          </tr>
          <tr>
            <td scope="row">3</td>
            <td>Norway (national)</td>
            <td>5.5M</td>
            <td>$1.1B (NOK 12B)</td>
            <td>$750M (NOK 8B)</td>
            <td style="color: #4caf50; font-weight: 600;">+$375M</td>
            <td>National budget replacement</td>
          </tr>
          <tr>
            <td scope="row">5</td>
            <td>Norway + USA (pilots)</td>
            <td>6M</td>
            <td>$5B</td>
            <td>$4B</td>
            <td style="color: #4caf50; font-weight: 600;">+$1B</td>
            <td>US private insurance + Medicare</td>
          </tr>
          <tr>
            <td scope="row">10</td>
            <td>Global (Norway + USA)</td>
            <td>345M</td>
            <td>$150B</td>
            <td>$100B</td>
            <td style="color: #4caf50; font-weight: 600;">+$50B</td>
            <td>Government contracts + subscriptions</td>
          </tr>
        </tbody>
      </table>

      <h3>Revenue Breakdown (Year 10)</h3>

      <ul>
        <li><strong>Government Contracts:</strong> $80B (Norway: $11B, USA Medicare/Medicaid: $69B)</li>
        <li><strong>Employer Partnerships:</strong> $40B (Fortune 500 + SMBs replacing health insurance)</li>
        <li><strong>Direct Consumer Subscriptions:</strong> $20B (premium tiers, elective services)</li>
        <li><strong>Philanthropic Grants:</strong> $10B (Gates Foundation, Bloomberg, others covering underserved)</li>
      </ul>

      <h3>Cost Structure (Year 10)</h3>

      <ul>
        <li><strong>Automated Pharmacy Operations:</strong> $30B (raw materials, equipment maintenance)</li>
        <li><strong>Parametric Hospital Operations:</strong> $25B (energy, staff, module maintenance)</li>
        <li><strong>hAPI Platform:</strong> $15B (server infrastructure, AI model training, engineers)</li>
        <li><strong>Medical Staff:</strong> $20B (doctors, nurses, pharmacists — reduced vs traditional due to AI)</li>
        <li><strong>R&amp;D &amp; Expansion:</strong> $10B (new markets, technology improvements)</li>
      </ul>

      <p><strong>Key Insight:</strong> Savings from automation ($1.5T) are more than sufficient to fund universal coverage. This is <strong>economically sustainable</strong>, not charity. Profit margins (33% by Year 10) enable continuous reinvestment in technology and expansion.</p>

    </section>

    <section aria-labelledby="integration">
      <h2 id="integration">Integration with Other Pub Ventures</h2>

      <p><strong>pub.healthcare is the flagship mission that all other ventures support:</strong></p>

      <h3>SYRE™ (Footwear Manufacturing)</h3>
      <ul>
        <li><strong>3D Printing Technology Sharing:</strong> SYRE™'s carbon fiber and advanced composites 3D printing extends to parametric hospital construction materials</li>
        <li><strong>Manufacturing Process:</strong> On-demand production model for shoes → on-demand medication production</li>
        <li><strong>Donation Program:</strong> "1:1 model" (1 purchase = 1 free pair donated) extends to healthcare (1 paying patient → 1 free patient)</li>
        <li><strong>Brand Alignment:</strong> Ethical manufacturing, sustainability, accessible to all</li>
      </ul>

      <h3>SPEIS (Aerospace Engineering)</h3>
      <ul>
        <li><strong>Structural Engineering:</strong> Aerospace-grade parametric optimization for hospital design (load calculations, materials science)</li>
        <li><strong>Materials Science:</strong> Carbon fiber, advanced composites, and lightweight structures for modular hospital pods</li>
        <li><strong>AI³ Integration:</strong> Building automation systems (HVAC, biosafety monitoring, energy management) adapted from spacecraft control</li>
        <li><strong>Precision Manufacturing:</strong> Aerospace quality standards applied to medical device production</li>
      </ul>

      <h3>Norwegian Hedge (Investment Fund)</h3>
      <ul>
        <li><strong>Financing:</strong> Investment fund profits finance pub.healthcare expansion (venture capital for USA rollout)</li>
        <li><strong>Trading Profits Subsidy:</strong> Hedge fund returns subsidize free healthcare operations in underserved markets</li>
        <li><strong>Ruby Bot Infrastructure:</strong> Algorithmic trading systems share backend with hAPI platform (Ruby/Rails expertise)</li>
        <li><strong>Risk Management:</strong> Financial modeling for healthcare cost projections and government contract negotiations</li>
      </ul>

      <h3>Unified Mission Statement</h3>

      <p style="font-weight: 600; color: var(--accent-color); font-size: 1.1rem; margin: 1.5rem 0; padding: 1rem; background: #ffebee; border-left: 4px solid var(--accent-color);">
        "All pub ventures exist to support the flagship mission: Free healthcare for all. SYRE™ provides manufacturing technology. SPEIS provides engineering expertise. Norwegian Hedge provides capital. pub.healthcare delivers the mission."
      </p>

    </section>

    <section aria-labelledby="visualizations">
      <h2 id="visualizations">ECharts Visualizations</h2>

      <p><strong>Interactive data visualizations to demonstrate global impact:</strong></p>

      <h3>1. Global Coverage Expansion Map</h3>
      <ul>
        <li><strong>Chart Type:</strong> Geo/Timeline animation (<a href="https://echarts.apache.org/examples/en/editor.html?c=lines-ny" target="_blank">lines-ny style</a>)</li>
        <li><strong>Data:</strong> Norway pilot (2027) → National rollout (2029) → USA pilots (2030) → USA national (2035) → Europe (2040)</li>
        <li><strong>Metrics:</strong> Patients served, hospitals deployed, pharmacies online</li>
      </ul>

      <h3>2. Healthcare Cost Savings Waterfall</h3>
      <ul>
        <li><strong>Chart Type:</strong> Waterfall chart with breakdown</li>
        <li><strong>Flow:</strong> $4.5T US baseline → -$1.8T pharma automation → -$300B hospital efficiency → -$200B AI diagnostics → $2.2T final cost → $1.5T savings redirect to universal coverage</li>
      </ul>

      <h3>3. Patient Impact Timeline</h3>
      <ul>
        <li><strong>Chart Type:</strong> Area chart with milestones</li>
        <li><strong>Growth:</strong> 50K (Year 1) → 500K (Year 2) → 5.5M (Year 3) → 6M (Year 5) → 345M (Year 10)</li>
        <li><strong>Annotations:</strong> Key events (Norwegian approval, USA Medicare contract, break-even point)</li>
      </ul>

      <h3>4. Technology Integration Diagram</h3>
      <ul>
        <li><strong>Chart Type:</strong> Sankey flow diagram</li>
        <li><strong>Connections:</strong> Patient symptoms → hAPI AI → Diagnosis → Automated Pharmacy OR Parametric Hospital → Outcome (zero cost to patient)</li>
        <li><strong>Sub-flows:</strong> SYRE™ → Hospital construction, SPEIS → Engineering, Norwegian Hedge → Financing</li>
      </ul>

      <h3>5. Body/Organ-Specific Health Data</h3>
      <ul>
        <li><strong>Chart Type:</strong> Anatomical visualization (<a href="https://echarts.apache.org/examples/en/editor.html?c=geo-organ" target="_blank">geo-organ style</a>)</li>
        <li><strong>Use Case:</strong> Patient health dashboard showing medication impact on organs, disease progression tracking</li>
      </ul>

      <div class="warning_box" role="note">
        <div class="warning_title">Implementation Note</div>
        <p>ECharts visualizations will be embedded in future iterations of this business plan and the pub.healthcare web platform. Interactive dashboards for Innovasjon Norge reviewers, Helsedirektoratet stakeholders, and patients.</p>
      </div>

    </section>

    <section aria-labelledby="risks">
      <h2 id="risks">Risks and mitigations</h2>

      <ul>
        <li><strong>Regulatory Approval:</strong> Norwegian Medicines Agency and FDA approval for pharmaceutical production
          <ul>
            <li><em>Mitigation:</em> Engage regulators early, GMP compliance, third-party quality certification, phased rollout</li>
          </ul>
        </li>
        <li><strong>Clinical Adoption:</strong> Doctors and patients skeptical of AI diagnostics and automated medication
          <ul>
            <li><em>Mitigation:</em> Human-in-the-loop design, transparent AI explanations, UNN co-design with clinicians, extensive patient education</li>
          </ul>
        </li>
        <li><strong>Cybersecurity &amp; Privacy:</strong> PHI breaches could destroy trust and violate GDPR/HIPAA
          <ul>
            <li><em>Mitigation:</em> OpenBSD hardening, zero-trust architecture, on-premise inference (no cloud), regular security audits, red-team testing</li>
          </ul>
        </li>
        <li><strong>Supply Chain:</strong> Raw materials for pharmaceutical production, hospital construction components
          <ul>
            <li><em>Mitigation:</em> Dual sourcing, 6-month inventory buffers, local fabrication partnerships, WHO Essential Medicines focus (common compounds)</li>
          </ul>
        </li>
        <li><strong>Government Funding Dependence:</strong> Norwegian pilot relies on Helsedirektoratet contracts
          <ul>
            <li><em>Mitigation:</em> Demonstrate clear cost savings (30%), diversify revenue with USA market, philanthropic partnerships, employer contracts</li>
          </ul>
        </li>
        <li><strong>USA Political Resistance:</strong> Private insurance lobby may fight universal healthcare disruption
          <ul>
            <li><em>Mitigation:</em> Start with Medicare/Medicaid (government programs), partner with progressive states (California, New York), employer demand for cost savings</li>
          </ul>
        </li>
        <li><strong>Technology Scalability:</strong> AI models, pharmacy automation may not scale to 345M patients
          <ul>
            <li><em>Mitigation:</em> Cloud-native architecture (while keeping PHI on-premise), distributed pharmacy network (not centralized), continuous R&D investment</li>
          </ul>
        </li>
      </ul>

    </section>

    <section aria-labelledby="ethics">
      <h2 id="ethics">Privacy, safety, and ethics</h2>

      <h3>Privacy by Design</h3>
      <ul>
        <li><strong>Data Minimization:</strong> Only collect essential health information, no behavioral tracking or advertising</li>
        <li><strong>On-Premise Inference:</strong> AI diagnostics run locally, no patient data sent to cloud providers</li>
        <li><strong>Patient Data Sovereignty:</strong> Patients own their health records, can export/delete at any time</li>
        <li><strong>Auditability:</strong> Every AI decision logged and reviewable by clinicians and patients</li>
        <li><strong>Encryption:</strong> All data encrypted in transit (TLS 1.3) and at rest (AES-256)</li>
      </ul>

      <h3>Patient Agency &amp; Human Oversight</h3>
      <ul>
        <li><strong>Opt-In AI:</strong> Patients choose whether to use AI diagnostics or traditional doctor consultations</li>
        <li><strong>Human-in-the-Loop:</strong> All AI prescriptions reviewed by licensed physicians before fulfillment</li>
        <li><strong>Transparent Explanations:</strong> AI provides reasoning for diagnoses in plain language</li>
        <li><strong>Clinical Override:</strong> Doctors can always override AI recommendations</li>
        <li><strong>Second Opinions:</strong> Patients can request human specialist consultation at any time (zero cost)</li>
      </ul>

      <h3>Equity &amp; Universal Access</h3>
      <ul>
        <li><strong>Zero Cost Barrier:</strong> No patient turned away due to inability to pay</li>
        <li><strong>Rural Access:</strong> Distributed pharmacy network serves communities without hospitals</li>
        <li><strong>Language Support:</strong> hAPI platform in Norwegian, English, Arabic, Polish, Somali (Norway's major languages)</li>
        <li><strong>Disability Accessibility:</strong> WCAG 2.1 AAA compliance for web/mobile interfaces</li>
        <li><strong>Cross-Subsidization:</strong> Profitable services (premium care) fund free care for underserved</li>
      </ul>

      <h3>Ethical AI Governance</h3>
      <ul>
        <li><strong>Bias Monitoring:</strong> Regular audits for racial, gender, age bias in AI diagnostics</li>
        <li><strong>Clinical Validation:</strong> All AI models tested against diverse patient populations</li>
        <li><strong>Explainability:</strong> No "black box" algorithms — all decisions traceable</li>
        <li><strong>Ethics Board:</strong> Independent advisory board with patients, doctors, ethicists, technologists</li>
      </ul>

    </section>

    <section aria-labelledby="success">
      <h2 id="success">Success Criteria</h2>

      <p><strong>Norwegian Pilot (Year 1-2):</strong></p>
      <ul>
        <li>✓ Innovasjon Norge funding secured (NOK 25M) for UNN partnership</li>
        <li>✓ Helsedirektoratet partnership established for national rollout pathway</li>
        <li>✓ Norwegian Medicines Agency approval for automated pharmaceutical production</li>
        <li>✓ UNN pilot demonstrates 30% cost reduction (government audit verified)</li>
        <li>✓ Patient satisfaction >90% (10K+ patient survey)</li>
        <li>✓ Medication wait times <24 hours (vs 2-5 days baseline)</li>
        <li>✓ Specialist wait times <1 week (vs 6 months baseline)</li>
      </ul>

      <p><strong>Norwegian National (Year 3-5):</strong></p>
      <ul>
        <li>✓ Expansion to all 4 health regions (Helse Nord/Midt/Vest/Sør-Øst)</li>
        <li>✓ Helsenorge.no full integration (5.5M Norwegians with access)</li>
        <li>✓ 50+ parametric hospital modules deployed</li>
        <li>✓ 200+ community pharmacy ATMs in rural areas</li>
        <li>✓ Zero medication stockouts (100% availability of WHO Essential Medicines)</li>
      </ul>

      <p><strong>USA Expansion (Year 5-10):</strong></p>
      <ul>
        <li>✓ Medicare/Medicaid pilot partnerships secured (5+ states)</li>
        <li>✓ FDA approval for pharmaceutical production (GMP certification)</li>
        <li>✓ Fortune 500 employer partnerships (50+ companies, 5M employees)</li>
        <li>✓ 100M Americans served (30% of population)</li>
        <li>✓ $500B annual cost savings demonstrated (vs traditional insurance)</li>
      </ul>

      <p><strong>Global Impact (Year 10):</strong></p>
      <ul>
        <li>✓ 345M people served with free healthcare (Norway + USA)</li>
        <li>✓ $1.5 trillion annual savings reinvested in coverage expansion</li>
        <li>✓ 500K jobs created (engineers, doctors, pharmacists, AI specialists)</li>
        <li>✓ Healthcare bankruptcy eliminated (USA: 530K families/year saved)</li>
        <li>✓ Business plan demonstrates path to universal global healthcare (8 billion people)</li>
      </ul>

      <p><strong>Design Excellence (Tadao Ando Aesthetic):</strong></p>
      <ul>
        <li>✓ Master.json v502.0.0 design system integrated (concrete, light, void, radical whitespace)</li>
        <li>✓ Healing architecture: Hospital spaces designed for recovery (natural light, noise reduction, biophilic design)</li>
        <li>✓ Minimalist interfaces: hAPI platform emphasizes clarity and ease of use (no dark patterns)</li>
      </ul>

    </section>

    <section aria-labelledby="roadmap">
      <h2 id="roadmap">Implementation Roadmap</h2>

      <table role="grid" aria-label="Implementation timeline">
        <caption>Phased Rollout: Norway to Global</caption>
        <thead>
          <tr>
            <th scope="col">Phase</th>
            <th scope="col">Timeline</th>
            <th scope="col">Geography</th>
            <th scope="col">Key Milestones</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td scope="row"><strong>1: Norwegian Pilot</strong></td>
            <td>Months 0-18</td>
            <td>UNN (Tromsø)</td>
            <td>50-bed parametric wing + automated pharmacy + hAPI platform</td>
          </tr>
          <tr>
            <td scope="row"><strong>2: Norwegian Expansion</strong></td>
            <td>Months 18-36</td>
            <td>Northern Norway</td>
            <td>5 community pharmacy ATMs + 50K patients served</td>
          </tr>
          <tr>
            <td scope="row"><strong>3: Norwegian National</strong></td>
            <td>Years 3-5</td>
            <td>All 4 health regions</td>
            <td>5.5M Norwegians + Helsenorge.no integration</td>
          </tr>
          <tr>
            <td scope="row"><strong>4: USA Pilots</strong></td>
            <td>Years 5-7</td>
            <td>Rural states + Medicare</td>
            <td>10 hospitals + 500K patients + FDA approval</td>
          </tr>
          <tr>
            <td scope="row"><strong>5: USA National Rollout</strong></td>
            <td>Years 7-10</td>
            <td>50 states</td>
            <td>340M Americans + employer partnerships</td>
          </tr>
          <tr>
            <td scope="row"><strong>6: Global Expansion</strong></td>
            <td>Years 10+</td>
            <td>Europe, Asia, Africa</td>
            <td>Replicate Norway model worldwide (8B people)</td>
          </tr>
        </tbody>
      </table>

    </section>

    <section aria-labelledby="links">
      <h2 id="links">Contact &amp; Resources</h2>

      <p><strong>Website:</strong> <a href="https://pub.healthcare/" aria-label="Visit pub.healthcare">pub.healthcare</a></p>

      <p><strong>Email:</strong> <a href="mailto:info@pub.healthcare" aria-label="Email pub.healthcare">info@pub.healthcare</a></p>

      <p><strong>Funding Inquiries:</strong> <a href="mailto:funding@pub.healthcare" aria-label="Funding inquiries">funding@pub.healthcare</a></p>

      <p><strong>Clinical Partnerships:</strong> <a href="mailto:clinical@pub.healthcare" aria-label="Clinical partnerships">clinical@pub.healthcare</a></p>

      <div class="warning_box" role="note" style="margin-top: 1.5rem;">
        <div class="warning_title">Innovasjon Norge Application Status</div>
        <p><strong>Funding Request:</strong> NOK 25 million for Norwegian pilot (UNN partnership)</p>
        <p><strong>Application Period:</strong> October 2025</p>
        <p><strong>Expected Decision:</strong> Q1 2026</p>
        <p><strong>Project Start:</strong> Q2 2026 (upon funding approval)</p>
      </div>

    </section>

    <footer>
      <p><strong>© 2025 PubHealthcare AS</strong> — Free Healthcare for USA + Norway (345 Million People)</p>

      <p style="margin-top: 0.5rem; font-size: 0.9rem;">Flagship company integrating SYRE™ 3D printing, SPEIS aerospace engineering, and Norwegian Hedge financing</p>

      <p style="margin-top: 0.5rem; font-size: 0.85rem; color: var(--neutral-dark);">Framework: master.json v502.0.0 | Design: Tadao Ando aesthetic (concrete, light, void, radical whitespace)</p>

      <div class="footer-links" aria-label="Social links" style="margin-top: 1rem;">

        <a href="https://www.linkedin.com" aria-label="LinkedIn">LinkedIn</a>

        <a href="https://www.twitter.com" aria-label="Twitter">Twitter</a>

        <a href="https://www.facebook.com" aria-label="Facebook">Facebook</a>

      </div>

    </footer>

  </main>

</body>

</html>

